A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.

The case counts seem to be dropping. But health officials say that's because violence in the Democratic Republic of Congo ...

Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...

In other developments, the recently identified clade 1a virus that has the APOBEC3 mutation, linked to more transmissibility, ...

The global community rallied after both Africa CDC and WHO declared the mpox outbreak in Africa a public health emergency in August 2024. Over a billion dollars was pledged to the control effort ...

The violence has interrupted mpox control and reporting work. The lack of funding is the result of the abrupt freeze in U.S. foreign aid instituted after President Trump took office on Jan. 20 ...